Cargando…

Patients with Inflammatory Bowel Disease Have Heterogeneous Treatment Preferences That Are Largely Determined by the Avoidance of Abdominal Pain and Side Effects [P-POWER IBD Study]

BACKGROUND AND AIMS: Patient-centric management of inflammatory bowel disease [IBD] is important, with consensus considering patient-reported outcomes alongside clinical and endoscopic assessment by healthcare providers. However, evidence regarding patients’ treatment priorities is still limited. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Louis, Edouard, Siegel, Corey A, James, Barbara, Heidenreich, Sebastian, Krucien, Nicolas, Ghosh, Subrata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024545/ https://www.ncbi.nlm.nih.gov/pubmed/36130188 http://dx.doi.org/10.1093/ecco-jcc/jjac130

Ejemplares similares

Clinicians' preferences for managing aneurysmal subarachnoid hemorrhage using endothelin receptor antagonists
por: Heidenreich, Sebastian, et al.
Publicado: (2023)

Diet and Nutrition in IBD—Progress and Gaps
por: Raman, Maitreyi, et al.
Publicado: (2019)

Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases
por: Ghosh, Subrata, et al.
Publicado: (2017)

The introduction of the IBD Disk in Poland – a new tool for assessing disability in patients with inflammatory bowel disease
por: Eder, Piotr, et al.
Publicado: (2019)

Food avoidance and fasting in patients with inflammatory bowel disease: Experience from the Nancy IBD nutrition clinic
por: Bonsack, Olivier, et al.
Publicado: (2023)

The Other Side of Malnutrition in Inflammatory Bowel Disease (IBD): Non-Alcoholic Fatty Liver Disease
por: Gibiino, Giulia, et al.
Publicado: (2021)

Bowel Location Rather Than Disease Subtype Dominates Transcriptomic Heterogeneity in Pediatric IBD
por: Venkateswaran, Suresh, et al.
Publicado: (2018)

Willingness to Wait for a Vaccine Against COVID-19: Results of a Preference Survey
por: Tervonen, Tommi, et al.
Publicado: (2020)

Patient Preferences for Treatment of Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: A Cross-country Choice Experiment
por: Collacott, Hannah, et al.
Publicado: (2023)

Linking Genotype with Phenotype in Inflammatory Bowel Disease – Will We Ever Have Reagent Standard Patients?
por: Ghosh, Subrata
Publicado: (2000)

Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists
por: Bilal, Mohammad, et al.
Publicado: (2017)

Fr497 INCIDENCE AND OUTCOMES OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Khan, Shahab R., et al.
Publicado: (2021)

Emotional state should not be used to differentiate IBD from IBS – Authors' reply
por: Iacucci, Marietta, et al.
Publicado: (2020)

Future of Endoscopy in Inflammatory Bowel Diseases (IBDs)
por: Agrawal, Laksh S, et al.
Publicado: (2022)

Helminth Lessons in Inflammatory Bowel Diseases (IBD)
por: Atagozli, Tyler, et al.
Publicado: (2023)

Tests that now deserve to be more widely adopted in IBD clinical practice
por: Labarile, Nunzia, et al.
Publicado: (2020)

Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD
por: Tindemans, Irma, et al.
Publicado: (2020)

Nutritional Assessment in Inflammatory Bowel Disease (IBD)—Development of the Groningen IBD Nutritional Questionnaires (GINQ)
por: Peters, Vera, et al.
Publicado: (2019)

Endoscopic stricturotomy in the treatment of anastomotic strictures in inflammatory bowel disease (IBD) and non-IBD patients
por: Zhang, Long-Juan, et al.
Publicado: (2019)

Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
por: Park, Jihye, et al.
Publicado: (2021)

Not All that Strictures Is IBD: Gastric Heterotopia Leading to Perforation and Small Bowel Obstruction Mimicking IBD
por: Ralbovsky, Amariel, et al.
Publicado: (2022)

Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi Consensus
por: D’Amico, Ferdinando, et al.
Publicado: (2023)

Cognitive Behavioral Therapy for Insomnia: A Promising Treatment for Insomnia, Pain, and Depression in Patients With IBD
por: Salwen-Deremer, Jessica K, et al.
Publicado: (2020)

Patients with IBD Want to Talk About Sleep and Treatments for Insomnia with Their Gastroenterologist
por: Salwen-Deremer, Jessica K., et al.
Publicado: (2023)

Controlled drug release for inflammatory bowel disease (IBD)
por: Asha, D, et al.
Publicado: (2020)

COVID-19 Vaccination in Inflammatory Bowel Disease (IBD)
por: Kubas, Aleksandra, et al.
Publicado: (2022)

Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD)
por: Furfaro, Federica, et al.
Publicado: (2022)

Comparison the effects and side effects of Covid-19 vaccination in patients with inflammatory bowel disease (IBD): a systematic scoping review
por: Tabesh, Elham, et al.
Publicado: (2022)

The gut microbiota heterogeneity and assembly changes associated with the IBD
por: Sun, Yang, et al.
Publicado: (2019)

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
por: Khan, Israr, et al.
Publicado: (2019)

Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative Colitis
por: Ghosh, Subrata, et al.
Publicado: (2021)

Chronic Abdominal Pain in IBD Research Initiative: Unraveling Biological Mechanisms and Patient Heterogeneity to Personalize Treatment and Improve Clinical Outcomes
por: Hurtado-Lorenzo, Andrés, et al.
Publicado: (2021)

From bowel inflammation to the bone and joints: musculoskeletal examination in inflammatory bowel disease (IBD)
por: Tavassoli, Samane, et al.
Publicado: (2021)

Thromboembolic tendency (TE) in IBD (inflammatory bowel disease) patients
por: Canero, A, et al.
Publicado: (2010)

The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs)
por: Vadasz, Zahava, et al.
Publicado: (2015)

Improving pediatric Inflammatory Bowel Disease (IBD) follow-up
por: Dykes, Dana, et al.
Publicado: (2016)

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors
por: Nguyen, Geoffrey C, et al.
Publicado: (2019)

Change in bowel habits during menstruation: are IBD patients different?
por: Lahat, Adi, et al.
Publicado: (2020)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Epidemiology of IBD
por: Coward, Stephanie, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Cancer and IBD
por: Murthy, Sanjay K, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hklu29miv6pcf67d7j9k7dp99b